J&J Medical Connect
INVEGA SUSTENNA®

(paliperidone palmitate)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

INVEGA SUSTENNA® (paliperidone palmitate)

Patient Medical Information

+ Save link

Does INVEGA SUSTENNA Prefilled Syringe Contain Latex?

Last Updated: 11/01/2024

Summary

The materials do not contain latex as an ingredient. However, we cannot guarantee that the materials do not come in contact with latex during the manufacturing or packaging process (e.g. latex gloves).1

What are the ingredients in INVEGA SUSTENNA?

  • Active ingredient: paliperidone palmitate.2
  • Inactive ingredients: polysorbate 20, polyethylene glycol 4000, citric acid monohydrate, sodium dihydrogen phosphate monohydrate, sodium hydroxide, and water for injection.2

Additional Information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest use in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the MEDICATION GUIDE for INVEGA SUSTENNA.2

 

References

Show
1 Data on File. INVEGA SUSTENNA (paliperidone palmitate) - Patient Safety and Compliance Information of Excipients (EXC) and Immediate Containers (IMC); 2024.  
2 INVEGA SUSTENNA (paliperidone palmitate) extended-release injectable suspension [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+SUSTENNA-pi.pdf